ABHITRUST-250

Advanced Hormonal Therapy for Metastatic Prostate Cancer

ABHITRUST-250 is a prescription-based anticancer medicine containing Abiraterone Acetate 250mg, indicated for the treatment of metastatic castration-resistant prostate cancer (mCRPC) and metastatic hormone-sensitive prostate cancer (mHSPC). It belongs to a class of medicines known as androgen biosynthesis inhibitors, which help reduce the production of testosterone and other male hormones (androgens) that stimulate the growth of prostate cancer cells.

ABHITRUST-250 is commonly prescribed in combination with prednisone or prednisolone as part of a comprehensive hormone therapy regimen. By lowering androgen levels, it helps slow disease progression, delay cancer growth, and improve overall treatment outcomes in patients with advanced prostate cancer.

Key Benefits of ABHITRUST-250

• Effective treatment for advanced and metastatic prostate cancer
• Contains Abiraterone Acetate 250mg
• Helps reduce testosterone and androgen production
• Slows the growth and spread of prostate cancer cells
• Used in metastatic castration-resistant prostate cancer (mCRPC)
• Also indicated for metastatic hormone-sensitive prostate cancer (mHSPC)
• Commonly prescribed with prednisone or prednisolone
• Supports long-term prostate cancer management under specialist supervision

Uses of ABHITRUST-250

ABHITRUST-250 is prescribed for the treatment of:

• Metastatic Castration-Resistant Prostate Cancer (mCRPC)
• Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
• Advanced prostate cancer requiring androgen suppression therapy
• Hormone-sensitive prostate cancer as part of combination therapy

Why Choose ABHITRUST-250?

ABHITRUST-250 is a clinically proven hormone therapy trusted by oncologists and urologists worldwide for the treatment of advanced prostate cancer. Its targeted mechanism of action helps provide effective androgen suppression, making it an essential component of modern prostate cancer treatment protocols.

Important Safety Information

• Prescription-only anticancer medicine.
• Use only under the supervision of a qualified oncologist.
• Regular monitoring of liver function, blood pressure, potassium levels, and overall health is recommended during treatment.
• Inform your doctor about liver disease, heart conditions, diabetes, or any other medical conditions before starting therapy.
• Do not discontinue treatment without consulting your physician.
• Keep out of reach of children.